ODI Pharma24. Jan. 20232 Min.ODI Pharma receives approval from the Office for Registration of Medicinal Products in PolandODI Pharma AB (“ODI” or the “Company”) announces today that the Company has received approval from the Office for Registration of...
ODI Pharma16. Dez. 20222 Min.Announcement from the Annual General Meeting in ODI Pharma AB (publ) This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
ODI Pharma16. Dez. 20222 Min.Kommuniké från årsstämma i ODI Pharma AB (publ)Idag den 16 december 2022 hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...
ODI Pharma25. Nov. 20223 Min.ODI Pharma AB: Publication of interim report Q1 2022/2023 ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report concerning the period July 2022 to September 2022. The report...
ODI Pharma25. Nov. 20221 Min.ODI Pharma AB publishes the annual report for the fiscal year 2021/2022The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...